Taylor Devices: A Strong Buy Signal Despite Past Challenges
Finance

Taylor Devices: A Strong Buy Signal Despite Past Challenges

authorBy Morgan Housel
DateAug 21, 2026
Read time2 min
This article examines Taylor Devices' recent financial performance and future prospects, highlighting the significance of its substantial backlog increase and strong position in the Aerospace & Defense sector.

Unlocking Value: Taylor Devices' Path to Future Growth

Navigating Past Weakness: The FY2026 Turnaround Story

Despite a challenging fiscal year 2026, Taylor Devices (TAYD) has demonstrated remarkable resilience, underscored by an impressive 154% sequential surge in its backlog, reaching a record $52.8 million. This significant increase fundamentally alters the perception of the company's recent performance, suggesting that previous delays are now translating into concrete orders.

Robust Demand Confirmed: Backlog Growth Beyond Expectations

Even when excluding a one-time $19 million order, the company's backlog stands at a robust $34 million. This sustained growth unequivocally supports management's assertion that demand for Taylor Devices' products remains strong and consistent. The conversion of previously delayed orders into a substantial backlog reinforces confidence in the company's operational capabilities and market position.

Aerospace and Defense: A Foundation for Stability and Growth

A critical factor contributing to Taylor Devices' stability is the composition of its backlog. An impressive 92% of the current backlog is derived from the Aerospace & Defense sector. This concentration provides high revenue visibility and ensures margin stability, laying a solid foundation for financial performance in fiscal year 2027. The inherent long-term nature of defense contracts further strengthens this outlook.

Attractive Investment Proposition: Valuation and Future Upside

From an investment perspective, Taylor Devices presents an compelling opportunity. With a forward price-to-earnings (P/E) ratio of 16, a healthy cash reserve, and a complete absence of debt, the company exhibits strong financial health. Furthermore, analysts project a 25% upside over the next three years, indicating an attractive risk-reward profile for potential investors seeking growth in a stable sector.

More Articles
Finance
Valor Gold: A New Era for High-Grade Gold in Canada's Northwest Territories
Valor Gold, a recent spin-off from Seabridge Gold, holds significant high-grade gold assets in Canada's Northwest Territories. While currently trading above $3, its fair value considering a six-year production timeline suggests a more attractive entry point below $2.50. Both projects boast impressive recovery rates exceeding 90% and benefit from strong governmental support amidst the region's economic evolution. Investors should anticipate potential dilution of 30-50% before production, though current financial resources are sufficient to fund exploration and permitting activities until early 2028.
By Suze OrmanAug 21, 2026
Finance
Rapport Therapeutics: A Promising Horizon in Neurological Disorder Treatment
Rapport Therapeutics (RAPP) shows significant promise with its investigational drug, RAP-219. Its unique neuroanatomically selective pharmacology and extended half-life offer a distinct advantage, particularly in managing focal onset seizures and potentially bipolar mania. The company is well-capitalized to advance through Phase 3 trials, projecting financial stability into late 2029. While its valuation reflects high expectations, driven by early efficacy and broad therapeutic potential, further capital will likely be needed for full commercialization.
By Strive MasiyiwaAug 21, 2026
Finance
Mastering Options Trading with Key Technical Indicators
This article explores essential technical indicators for options trading, helping traders identify overbought/oversold conditions and market sentiment. It covers RSI, Bollinger Bands, Intraday Momentum Index, Money Flow Index, Put-Call Ratio, and Open Interest, providing insights into their application for effective short-term and long-term trading strategies. Understanding these tools can lead to more informed trading decisions.
By Michele FerreroAug 21, 2026
Finance
Brookfield Renewable's Strategic Nuclear Investment Set for Potential Growth
Brookfield Renewable's 17% stake in Westinghouse is poised for significant value appreciation as Westinghouse prepares for its public listing. Driven by surging AI-related energy demands, Westinghouse's established nuclear technology and substantial DOE loan facilities position it advantageously within the burgeoning nuclear energy sector. This move aligns with broader trends towards sustainable energy solutions and offers a promising outlook for BEP's investment portfolio.
By Morgan HouselAug 21, 2026
Finance
Cherry Hill Mortgage Investment Corporation Preferred Shares: A Risky Bet Despite High Yield
Cherry Hill Mortgage Investment Corporation's (CHMI-A) preferred shares offer a 9.45% yield but come with a high-risk rating. Despite the attractive yield, the shares are considered significantly overpriced, trading at 117.5% of their buy target. The minimal common equity cushion (0.92x preferred liquidation) offers insufficient protection compared to peers. This investment is suitable only for investors with a very high-risk tolerance, as numerous better-valued alternatives exist in the market.
By Fareed ZakariaAug 21, 2026